Drug intelligence / Profile preview

Calcirol

Development stage
Phase 4
Lead developer
Cadila Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Calcirol is a brand of cholecalciferol (Vitamin D3), a fat-soluble secosteroid essential for the regulation of calcium and phosphate homeostasis and the maintenance of bone health. It is primarily marketed in India by Cadila Pharmaceuticals and is available in various formulations, including granules in sachets, tablets, and oral solutions. As a pro-hormone, cholecalciferol is converted in the liver to 25-hydroxyvitamin D [25(OH)D] and subsequently in the kidneys to its active form, 1,25-dihydroxyvitamin D (calcitriol). This active metabolite binds to the nuclear Vitamin D receptor (VDR), promoting intestinal calcium absorption and bone mineralization. Calcirol is widely used for the treatment and prevention of vitamin D deficiency, rickets, osteomalacia, and osteoporosis, and it has been investigated for its potential benefits in critically ill patients and those with nephrotic syndrome.

Brand names
Calcirol
Other names
cholecalciferolVitamin D3colecalciferol
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Calcirol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcirol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call